Alimentary TractManagement and long-term follow-up of early stage H. pylori-associated gastric MALT-lymphoma in clinical practice: An Italian, multicentre study
Introduction
The gastrointestinal tract is the most frequent site of primary extranodal non-Hodgkin's lymphomas, and the stomach is the most common location accounting for more than 75% of such tumours [1], [2], [3]. Although primary gastric lymphoma remains a rare disease, its frequency has been rising in recent decades [4]. In particular, an incidence as high as 13.2 cases per 100,000 per year has been estimated in Northern Italy [5]. It is widely accepted that H. pylori infection is the main pathogenic factor for development of low-grade, marginal-zone-B-cell-lymphoma of MALT (MALT-lymphoma) of the stomach [6], [7]. Indeed, several studies have documented total regression of this lymphoma following H. pylori eradication in large series in which early stage neoplasia was diagnosed [8], [9], [10]. However, long-term follow-up data are still scanty in the literature, particularly regarding the efficacy of bacterial eradication in inducing prolonged remission and in preventing recurrence [8]. Different treatment approaches – chemotherapy, radiotherapy, immunotherapy, and surgery – are indicated as possible therapies in those patients who do not respond to H. pylori eradication, but no treatment guidelines are currently available.
The present study was designed to evaluate: (1) the efficacy of H. pylori eradication in inducing remission of low-grade MALT-lymphoma in stages I–II1 at prolonged follow-up and (2) the efficacy of further treatments in refractory or relapsing cases.
Section snippets
Study design
This was a retrospective, multicentre, Italian study involving 4 centres (1 Northern, 1 Central, and 2 Southern Italian locations). Only patients followed for at least 6 months post lymphoma diagnosis were considered.
Patients
Data for all consecutive patients with primary gastric MALT-lymphoma observed in the participating Centres between January 1993 and December 2006 were retrieved. Inclusion criteria were: (1) Age >18 years; (2) presence of low-grade, MALT-lymphoma of the stomach according to the
Study population
During the study period, 64 H. pylori infected patients with stage I/II1 gastric lymphoma were identified. Four patients were excluded due to a short follow-up (<6 months) and/or incomplete data availability. Sixty patients (males: 33, mean age: 60 years, range 23–80) were therefore enrolled. Stage I gastric lymphoma was diagnosed in 50 (83.3%) patients, and stage II1 disease in the remaining 10 (16.7%) cases. Follow-up time ranged from 7 to 156 months with a median of 65 months.
Lymphoma outcome following H. pylori eradication therapy
All patients
Discussion
The role of H. pylori infection in the pathogenesis of gastric MALT-lymphoma is widely recognised. Indeed, different guidelines suggest that bacterial eradication should be the first-line treatment for this neoplastic disease [14], [15], [16]. A review of 24 studies comprising 780 patients found that complete lymphoma regression following H. pylori eradication is achieved in 35–100% of patients [6]. Moreover, it has been observed that the regression rate inversely correlates with the neoplastic
Conflict of interest statement
None declared.
References (42)
- et al.
Gastric marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type: management of the disease
Dig Liver Dis
(2000) - et al.
High incidence of primary gastric lymphoma in northeastern Italy
Lancet
(1992) - et al.
A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group
Blood
(1994) - et al.
Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma
Ann Oncol
(1994) - et al.
Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori
Lancet
(1993) - et al.
Cervia II Working Group Report 2006: guidelines on diagnosis and treatment of Helicobacter pylori infection
Dig Liver Dis
(2007) - et al.
Diagnosis and posttreatment follow-up of Helicobacter pylori-positive gastric lymphoma of mucosa-associated lymphoid tissue: histology, polymerase chain reaction, or both?
Blood
(1996) - et al.
Primary and secondary antibiotic resistance of Helicobacter pylori strains isolated in central Italy during the years 1998–2002
Dig Liver Dis
(2003) - et al.
Prevalence of Helicobacter pylori resistance to antibiotics in Northeast Italy: a multicentre study
Dig Liver Dis
(2000) - et al.
The gastric marginal zone B-cell lymphoma of MALT type
Blood
(2000)